#AIDS Institute

Several makers of hepatitis C drugs are limiting health care providers’ access to the 340B Drug Pricing Program’s discounts.

The Supreme Court upholds the Affordable Care Act for a third time. Here’s a look at responses from health care advocates.

That’s a $267 million increase for HIV efforts from 2021. Plus, Biden’s 2022 budget invests $6.5 billion in health research.

The Viral Hepatitis National Strategic Plan for the United States, released by HHS, offers a road map for the next five years.

Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.

A coalition of LGBT groups sues the Trump administration over the rule. The lawsuit is “Whitman-Walker Clinic v. HHS.”

37 state Medicaid programs continue to restrict access to lifesaving medication—despite medical guidelines telling them not to.

Efforts to control viral hepatitis are falling behind, in part because of the growing opioid epidemic and homelessness crisis.

The change targets LGBT people and those with chronic conditions. Here’s how patient groups and Lambda Legal respond.

The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.

Insurance companies can no longer implement harmful co-pay accumulator policies.

Health coalition warns the federal government: People with chronic or serious conditions face growing costs at the pharmacy.

Advocacy organizations are “alarmed” by the findings.

He’ll oversee the FDA, Medicare and Medicaid at a time when soaring drug prices remain a contentious political topic.

As lawmakers postpone their vote, advocates and health groups respond to the bill that guts Medicaid. Here’s what they’re saying.

The Trump administration calls for fewer of the drug coverage reviews that ensure that health plans don’t discriminate.